|
K-1464 - Fungi Isolation in Egg Incubators Used in Assisted Reproduction: Potential Risk (click for details) |
|
|
|
K-1889 - Antimycotic Use in Veterans Affairs Medical Centers between 2007 and 2010 (click for details) |
|
|
|
M-1523a - The Airway Microbiome In Cystic Fibrosis: A Complex Ecosystem and Dynamics with potential implication for management (click for details) |
|
|
|
F1-1372 - Prophylactic and Therapeutic Effects of a Novel Arylamidine T-2307 in Murine Pneumocystis Pneumonia (click for details) |
|
|
|
M-308 - Differential Activities of Cefepime (CEF) and Ciprofloxacin (CIP) Alone and in Two-Drug Combinations with Various Antifungal Drugs on Monomicrobial (MM) and Polymicrobial (PM) Biofilms of Pseudomonas aeruginosa (Pa) and Aspergillus fumigatus (Af) (click for details) |
|
|
|
M-1508 - Prospective Multicenter Surveillance Study of Invasive Fungal Diseases in Hematopoietic Stem Cell Transplant Recipients and in Patients with Acute Myeloid Leukemia (click for details) |
|
|
|
A2-583 - Pharmacodynamics of Voriconazole (VCZ) in a Novel Dynamic in vitro Model of invasive Pulmonary Aspergillosis (IPA): Implications for in vitro Susceptibility Breakpoints and Targets for therapeutic Drug Monitoring (TDM) (click for details) |
|
|
|
M-1509 - Genotyping and Antifungal Susceptibilities of Cryptococcus neoformans Strains from HIV-associated Cryptococcal Meningitis in Cameroon (click for details) |
|
|
|
M-1507 - Incubation Period of Invasive Aspergillosis in Immunocompromised Patients Undergoing Aplasia Based on Parametric Survival Models (click for details) |
|
|
|
M-290 - Galactomannan Index: Variations According to the Aspergillus Species Involved (click for details) |
|
|
